| Sleep Apnea, Obstructive
Nuvigil vs Zepbound
Side-by-side clinical, coverage, and cost comparison for sleep apnea, obstructive.Deep comparison between: Nuvigil vs Zepbound with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsZepbound has a higher rate of injection site reactions vs Nuvigil based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Zepbound but not Nuvigil, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Nuvigil
Zepbound
At A Glance
Oral
Once daily
Wakefulness-promoting agent
SC injection
Once weekly
GIP/GLP-1 receptor agonist
Indications
- Sleep Apnea, Obstructive
- Narcolepsy
- Shift work disorder
- Obesity
- Sleep Apnea, Obstructive
Dosing
Sleep Apnea, Obstructive, Narcolepsy 150 mg to 250 mg taken orally once daily as a single dose in the morning.
Shift work disorder 150 mg taken orally once daily as a single dose approximately 1 hour prior to the start of the work shift.
Obesity Starting dose 2.5 mg SC once weekly for 4 weeks, escalating in 2.5 mg increments every 4 weeks; maintenance 5 mg, 10 mg, or 15 mg SC once weekly.
Sleep Apnea, Obstructive Starting dose 2.5 mg SC once weekly for 4 weeks, escalating in 2.5 mg increments every 4 weeks; maintenance 10 mg or 15 mg SC once weekly.
Contraindications
- Known hypersensitivity to modafinil or armodafinil or its inactive ingredients
- Personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
- Known serious hypersensitivity to tirzepatide or any excipient in ZEPBOUND
Adverse Reactions
Most common (>=5%) Headache, nausea, dizziness, insomnia
Serious Serious dermatologic reactions, DRESS/multiorgan hypersensitivity, angioedema and anaphylaxis, persistent sleepiness, psychiatric symptoms, cardiovascular events
Postmarketing Mouth sores (including mouth blistering and ulceration)
Most common (>=2%) Nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, injection site reactions, fatigue, hypersensitivity reactions, eructation, hair loss, gastroesophageal reflux disease, flatulence, abdominal distension, dizziness
Serious Risk of thyroid C-cell tumors, severe gastrointestinal reactions, acute kidney injury, acute gallbladder disease, acute pancreatitis, hypersensitivity reactions including anaphylaxis and angioedema, hypoglycemia, diabetic retinopathy complications, pulmonary aspiration
Postmarketing Acute pancreatitis, hemorrhagic and necrotizing pancreatitis, ileus, intestinal obstruction, severe constipation including fecal impaction, anaphylaxis, angioedema, pulmonary aspiration, acute renal failure or worsening of chronic renal failure
Pharmacology
Armodafinil is a wakefulness-promoting agent and indirect dopamine receptor agonist that binds to the dopamine transporter and inhibits dopamine reuptake, with wake-promoting actions similar to sympathomimetic agents, although its precise mechanism is unknown.
Tirzepatide is a dual GIP receptor and GLP-1 receptor agonist that selectively binds and activates both receptors, reducing body weight by decreasing caloric intake and affecting appetite regulation, stimulating glucose-dependent insulin secretion, reducing glucagon secretion, and delaying gastric emptying.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Nuvigil
- Covered on 5 commercial plans
- PA (10/12) · Step Therapy (10/12) · Qty limit (10/12)
Zepbound
- Covered on 5 commercial plans
- PA (9/12) · Step Therapy (0/12) · Qty limit (9/12)
UnitedHealthcare
Nuvigil
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Zepbound
- Covered on 4 commercial plans
- PA (5/8) · Step Therapy (4/8) · Qty limit (1/8)
Humana
Nuvigil
- Covered on 0 commercial plans
- PA (3/3) · Step Therapy (2/3) · Qty limit (3/3)
Zepbound
- Covered on 0 commercial plans
- PA (3/3) · Step Therapy (1/3) · Qty limit (0/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Nuvigil.
$25/fillfill
Zepbound Savings Card - Covered benefitCommercial or private insurance
Medicare, Medicaid, VA, TRICARE
Final cost depends on formulary coverage
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
NuvigilView full Nuvigil profile
ZepboundView full Zepbound profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.